Contrelle bladder stabilizer (size 2) - 30 pcs.

Contrelle Bladder Stabilizer - Help with Stress Urinary Incontinence

The Contrelle is a comfortable, discreet, easy-to-use bladder stabilizer designed to reduce or stop bladder leakage caused by Stress Urinary Incontinence (SUI). Contrelle restores the bladder neck and urethra to their natural position, helping to prevent urinary incontinence when laughing, coughing, sneezing or exercising. Contrelle is made of soft foam and is perfect for everyday use or for specific activities such as sports.

The effect of Contrelle has been clinically proven.

Contrelle will be helpful in the following cases:

• Urinary incontinence when coughing
• Urinary leakage when sneezing
• Urinary leakage when laughing
• Urinary leakage when exercising
• Urinary leakage when changing positions in bed

Using Contrelle for urinary incontinence

1. Each Contrelle can only be used once.

2. Contrelle is a device consisting of delicate, flexible wings made of soft foam, each attached to a string. Each set includes a stick-shaped applicator to aid insertion.

3. Contrelle is soft and gentle—similar to a tampon, so it's easy to insert and remove, and comfortable to wear.

4. Starting Contrelle is very simple and can be done in the comfort of your own home.

5. Contrelle effectively supports the urethra and bladder neck, keeping them in a natural position and preventing urinary incontinence.

6. You can use Contrelle daily for up to 16 hours (Published studies show that using Contrelle for up to 16 hours is safe without increasing the risk of infection). It should be removed before bed. You can wear it daily if you wish. There's no need to remove it during the day, even to use the bathroom. Each Contrelle can only be used once.

7. Contrelle is available in three sizes. To begin your Contrelle journey, you can use the starter kit, which contains one of each.

Why is it worth using Contrelle for stress urinary incontinence?

• This is a certified medical device with clinically proven effectiveness.
• Excellent protection against urine leakage during both everyday activities and physical activity.
• Convenient to use.
• Easy application using the applicator.
• Avoid wearing panty liners.
• Option to support therapy for organ prolapse.
• You can use it for short periods, such as during training, or long-term, i.e., throughout the day (up to 16 hours).
• Contrelle, when worn correctly, carries no risk of infection.

Clinically proven effectiveness in stress urinary incontinence

When properly inserted, Contrelle has been clinically proven to reduce the frequency and severity of urinary leakage. Furthermore, Contrelle is currently approved for reimbursement by the NHS in the UK.

Contraindications to the use of Contrelle

• Age under 18
• Pregnancy
• Childbirth within the last 3 months
• Vaginal irritation infection
• Toxic shock syndrome (TSS)
• Pelvic surgery within the last 6 months
• Treatment for pelvic cancer
• Moderate to severe vaginal prolapse
• Urinary tract or vaginal infection
• Severe or bothersome vaginal dryness (consult your doctor)
• Deficiency problems, which may cause difficulty with insertion or removal

Contrelle Bladder Stabilizer - Package Contents

• Contrelle bladder stabilizer - 30 pcs.
• Reusable applicator - 1 pc.
• Instruction manual

NOTE: Returns are not possible once the device has been unpacked.

This is a medical device. For safety, use it according to the instructions or label. If in doubt, consult a specialist, as this medical device may not be suitable for you.

Producer: VIVECA BIOMED LTD | Authorized representative: CS LIFESCIENCES EUROPE LTD | Distributor: ELMEDICO Robert Gabrysiak

³ Thyssen HH, Lose G. Długoterminowa skuteczność i bezpieczeństwo jednorazowego urządzenia dopochwowego (osłona trzymania moczu) w leczeniu wysiłkowego nietrzymania moczu u kobiet. Int Urogynecol J Dysfunkcja dna miednicy. 1997;8(3):130-2

⁴ Samotny Mouritsen. Wpływ urządzeń dopochwowych na ruchomość szyi pęcherza moczowego u kobiet z wysiłkowym nietrzymaniem moczu, Department of Obstretric and Gynecology, Gentofte Hospital, University of Copenhagen, Dania Acta Obstetricia et Gynecologica Scandinavica 2001 80: 428-431